China has already made tremendous inroads as a manufacturing center for the world. But now it's making enormous investments in R&D [1] to propel the country into the top ranks of world innovators. China has already passed Japan for R&D spending, notes an article by the BBC. And it's turning to companies like Sinovac to develop new drugs. Sinovac is pushing a new bird flu therapy [2]. China's R&D budget is growing at a rate of 20 percent a year, making it likely that a lot more Sinovacs will be created in the years ahead.
- check out the BBC report [3] on China's R&D strategy
Related Articles:
China drug czar executed for corruption [4]
China to overhaul drug safety regulations [5]
Bridge Pharma sees growth in China drug studies [6]
Links:
[1] http://www.fiercebiotech.com/story/novartis-maps-100m-rd-complex-in-china/2006-11-06
[2] http://www.fiercebiotech.com/story/sinovac-to-mass-produce-bird-flu-vaccine/2006-08-31
[3] http://news.bbc.co.uk/2/hi/asia-pacific/6912056.stm
[4] http://www.fiercebiotech.com/story/china-drug-czar-executed-for-corruption/2007-07-10
[5] http://www.fiercebiotech.com/story/china-to-overhaul-drug-safety-regulations/2007-06-07
[6] http://www.fiercebiotech.com/story/bridge-pharma-sees-growth-in-china-drug-studies/2006-11-27